Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of听glucose听in the proximal tubule. Inhibition of SGLT2 increases urinary听glucose听excretion by the kidneys, resulting in a reduction of plasma听glucose听levels in an insulin-independent manner. SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal听glucose听reabsorption from tubular fluid.
The global Empagliflozin API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Empagliflozin API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Empagliflozin API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Empagliflozin API include Piramal Enterprises Limited, Metrochem API Private Limited, ZCL Chemicals Limited, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikal, Morepen Laboratories and Zhejiang Huahai Pharmaceutial. Co., Ltd., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Empagliflozin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Empagliflozin API.
The Empagliflozin API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Empagliflozin API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Empagliflozin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Piramal Enterprises Limited
Metrochem API Private Limited
ZCL Chemicals Limited
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Hikal
Morepen Laboratories
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Lupin Ltd
Biocon Limited
Mehta API Pvt. Ltd
Danesh Kimia Pharmed
Shandong Haohong Biotechnology Co., Ltd.
Boryung Pharmaceutical Co., Ltd
Ami Lifesciences
Jiangsu Yutian Pharmaceutical Co., Ltd.
SGMR Pharmaceuticals
Kopran Limited
Segment by Type
笔耻谤颈迟测鈮�98%
Purity<98%
Segment by Application
Empagliflozin Tablets
Others
Production by Region
India
China
South Korea
Israel
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Empagliflozin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Empagliflozin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Empagliflozin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Empagliflozin API Market Overview
1.1 Product Definition
1.2 Empagliflozin API Segment by Type
1.2.1 Global Empagliflozin API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 笔耻谤颈迟测鈮�98%
1.2.3 Purity<98%
1.3 Empagliflozin API Segment by Application
1.3.1 Global Empagliflozin API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Empagliflozin Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Empagliflozin API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Empagliflozin API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Empagliflozin API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Empagliflozin API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Empagliflozin API Production Market Share by Manufacturers (2018-2023)
2.2 Global Empagliflozin API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Empagliflozin API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Empagliflozin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Empagliflozin API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Empagliflozin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Empagliflozin API, Product Offered and Application
2.8 Global Key Manufacturers of Empagliflozin API, Date of Enter into This Industry
2.9 Empagliflozin API Market Competitive Situation and Trends
2.9.1 Empagliflozin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Empagliflozin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Empagliflozin API Production by Region
3.1 Global Empagliflozin API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Empagliflozin API Production Value by Region (2018-2029)
3.2.1 Global Empagliflozin API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Empagliflozin API by Region (2024-2029)
3.3 Global Empagliflozin API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Empagliflozin API Production by Region (2018-2029)
3.4.1 Global Empagliflozin API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Empagliflozin API by Region (2024-2029)
3.5 Global Empagliflozin API Market Price Analysis by Region (2018-2023)
3.6 Global Empagliflozin API Production and Value, Year-over-Year Growth
3.6.1 India Empagliflozin API Production Value Estimates and Forecasts (2018-2029)
3.6.2 China Empagliflozin API Production Value Estimates and Forecasts (2018-2029)
3.6.3 South Korea Empagliflozin API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Israel Empagliflozin API Production Value Estimates and Forecasts (2018-2029)
4 Empagliflozin API Consumption by Region
4.1 Global Empagliflozin API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Empagliflozin API Consumption by Region (2018-2029)
4.2.1 Global Empagliflozin API Consumption by Region (2018-2023)
4.2.2 Global Empagliflozin API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Empagliflozin API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Empagliflozin API Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Empagliflozin API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Empagliflozin API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Empagliflozin API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Empagliflozin API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Empagliflozin API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Empagliflozin API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Empagliflozin API Production by Type (2018-2029)
5.1.1 Global Empagliflozin API Production by Type (2018-2023)
5.1.2 Global Empagliflozin API Production by Type (2024-2029)
5.1.3 Global Empagliflozin API Production Market Share by Type (2018-2029)
5.2 Global Empagliflozin API Production Value by Type (2018-2029)
5.2.1 Global Empagliflozin API Production Value by Type (2018-2023)
5.2.2 Global Empagliflozin API Production Value by Type (2024-2029)
5.2.3 Global Empagliflozin API Production Value Market Share by Type (2018-2029)
5.3 Global Empagliflozin API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Empagliflozin API Production by Application (2018-2029)
6.1.1 Global Empagliflozin API Production by Application (2018-2023)
6.1.2 Global Empagliflozin API Production by Application (2024-2029)
6.1.3 Global Empagliflozin API Production Market Share by Application (2018-2029)
6.2 Global Empagliflozin API Production Value by Application (2018-2029)
6.2.1 Global Empagliflozin API Production Value by Application (2018-2023)
6.2.2 Global Empagliflozin API Production Value by Application (2024-2029)
6.2.3 Global Empagliflozin API Production Value Market Share by Application (2018-2029)
6.3 Global Empagliflozin API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Piramal Enterprises Limited
7.1.1 Piramal Enterprises Limited Empagliflozin API Corporation Information
7.1.2 Piramal Enterprises Limited Empagliflozin API Product Portfolio
7.1.3 Piramal Enterprises Limited Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Piramal Enterprises Limited Main Business and Markets Served
7.1.5 Piramal Enterprises Limited Recent Developments/Updates
7.2 Metrochem API Private Limited
7.2.1 Metrochem API Private Limited Empagliflozin API Corporation Information
7.2.2 Metrochem API Private Limited Empagliflozin API Product Portfolio
7.2.3 Metrochem API Private Limited Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Metrochem API Private Limited Main Business and Markets Served
7.2.5 Metrochem API Private Limited Recent Developments/Updates
7.3 ZCL Chemicals Limited
7.3.1 ZCL Chemicals Limited Empagliflozin API Corporation Information
7.3.2 ZCL Chemicals Limited Empagliflozin API Product Portfolio
7.3.3 ZCL Chemicals Limited Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 ZCL Chemicals Limited Main Business and Markets Served
7.3.5 ZCL Chemicals Limited Recent Developments/Updates
7.4 Dr. Reddy's Laboratories
7.4.1 Dr. Reddy's Laboratories Empagliflozin API Corporation Information
7.4.2 Dr. Reddy's Laboratories Empagliflozin API Product Portfolio
7.4.3 Dr. Reddy's Laboratories Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Teva Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
7.5.2 Teva Pharmaceutical Industries Ltd. Empagliflozin API Product Portfolio
7.5.3 Teva Pharmaceutical Industries Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
7.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
7.6.2 Sun Pharmaceutical Industries Ltd. Empagliflozin API Product Portfolio
7.6.3 Sun Pharmaceutical Industries Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.7 Hikal
7.7.1 Hikal Empagliflozin API Corporation Information
7.7.2 Hikal Empagliflozin API Product Portfolio
7.7.3 Hikal Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Hikal Main Business and Markets Served
7.7.5 Hikal Recent Developments/Updates
7.8 Morepen Laboratories
7.8.1 Morepen Laboratories Empagliflozin API Corporation Information
7.8.2 Morepen Laboratories Empagliflozin API Product Portfolio
7.8.3 Morepen Laboratories Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Morepen Laboratories Main Business and Markets Served
7.7.5 Morepen Laboratories Recent Developments/Updates
7.9 Zhejiang Huahai Pharmaceutial. Co., Ltd.
7.9.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Corporation Information
7.9.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Product Portfolio
7.9.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
7.9.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
7.10 Lupin Ltd
7.10.1 Lupin Ltd Empagliflozin API Corporation Information
7.10.2 Lupin Ltd Empagliflozin API Product Portfolio
7.10.3 Lupin Ltd Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Lupin Ltd Main Business and Markets Served
7.10.5 Lupin Ltd Recent Developments/Updates
7.11 Biocon Limited
7.11.1 Biocon Limited Empagliflozin API Corporation Information
7.11.2 Biocon Limited Empagliflozin API Product Portfolio
7.11.3 Biocon Limited Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Biocon Limited Main Business and Markets Served
7.11.5 Biocon Limited Recent Developments/Updates
7.12 Mehta API Pvt. Ltd
7.12.1 Mehta API Pvt. Ltd Empagliflozin API Corporation Information
7.12.2 Mehta API Pvt. Ltd Empagliflozin API Product Portfolio
7.12.3 Mehta API Pvt. Ltd Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Mehta API Pvt. Ltd Main Business and Markets Served
7.12.5 Mehta API Pvt. Ltd Recent Developments/Updates
7.13 Danesh Kimia Pharmed
7.13.1 Danesh Kimia Pharmed Empagliflozin API Corporation Information
7.13.2 Danesh Kimia Pharmed Empagliflozin API Product Portfolio
7.13.3 Danesh Kimia Pharmed Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Danesh Kimia Pharmed Main Business and Markets Served
7.13.5 Danesh Kimia Pharmed Recent Developments/Updates
7.14 Shandong Haohong Biotechnology Co., Ltd.
7.14.1 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Corporation Information
7.14.2 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Product Portfolio
7.14.3 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Shandong Haohong Biotechnology Co., Ltd. Main Business and Markets Served
7.14.5 Shandong Haohong Biotechnology Co., Ltd. Recent Developments/Updates
7.15 Boryung Pharmaceutical Co., Ltd
7.15.1 Boryung Pharmaceutical Co., Ltd Empagliflozin API Corporation Information
7.15.2 Boryung Pharmaceutical Co., Ltd Empagliflozin API Product Portfolio
7.15.3 Boryung Pharmaceutical Co., Ltd Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Boryung Pharmaceutical Co., Ltd Main Business and Markets Served
7.15.5 Boryung Pharmaceutical Co., Ltd Recent Developments/Updates
7.16 Ami Lifesciences
7.16.1 Ami Lifesciences Empagliflozin API Corporation Information
7.16.2 Ami Lifesciences Empagliflozin API Product Portfolio
7.16.3 Ami Lifesciences Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.16.4 Ami Lifesciences Main Business and Markets Served
7.16.5 Ami Lifesciences Recent Developments/Updates
7.17 Jiangsu Yutian Pharmaceutical Co., Ltd.
7.17.1 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Corporation Information
7.17.2 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Product Portfolio
7.17.3 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.17.4 Jiangsu Yutian Pharmaceutical Co., Ltd. Main Business and Markets Served
7.17.5 Jiangsu Yutian Pharmaceutical Co., Ltd. Recent Developments/Updates
7.18 SGMR Pharmaceuticals
7.18.1 SGMR Pharmaceuticals Empagliflozin API Corporation Information
7.18.2 SGMR Pharmaceuticals Empagliflozin API Product Portfolio
7.18.3 SGMR Pharmaceuticals Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.18.4 SGMR Pharmaceuticals Main Business and Markets Served
7.18.5 SGMR Pharmaceuticals Recent Developments/Updates
7.19 Kopran Limited
7.19.1 Kopran Limited Empagliflozin API Corporation Information
7.19.2 Kopran Limited Empagliflozin API Product Portfolio
7.19.3 Kopran Limited Empagliflozin API Production, Value, Price and Gross Margin (2018-2023)
7.19.4 Kopran Limited Main Business and Markets Served
7.19.5 Kopran Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Empagliflozin API Industry Chain Analysis
8.2 Empagliflozin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Empagliflozin API Production Mode & Process
8.4 Empagliflozin API Sales and Marketing
8.4.1 Empagliflozin API Sales Channels
8.4.2 Empagliflozin API Distributors
8.5 Empagliflozin API Customers
9 Empagliflozin API Market Dynamics
9.1 Empagliflozin API Industry Trends
9.2 Empagliflozin API Market Drivers
9.3 Empagliflozin API Market Challenges
9.4 Empagliflozin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Piramal Enterprises Limited
Metrochem API Private Limited
ZCL Chemicals Limited
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Hikal
Morepen Laboratories
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Lupin Ltd
Biocon Limited
Mehta API Pvt. Ltd
Danesh Kimia Pharmed
Shandong Haohong Biotechnology Co., Ltd.
Boryung Pharmaceutical Co., Ltd
Ami Lifesciences
Jiangsu Yutian Pharmaceutical Co., Ltd.
SGMR Pharmaceuticals
Kopran Limited
听
听
*If Applicable.
